☰

Mei-Ling Liou, Ph.D. - Publications

Affiliations: 
2004 University of California, Los Angeles, Los Angeles, CA 
Area:
Oncology, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Liou ML, Lahusen T, Li H, Xiao L, Pauza CD. Reducing farnesyl diphosphate synthase levels activates Vγ9Vδ2 T cells and improves tumor suppression in murine xenograft cancer models. Frontiers in Immunology. 13: 1012051. PMID 36275712 DOI: 10.3389/fimmu.2022.1012051  0.315
1999 Liou HC, Jin Z, Tumang J, Andjelic S, Smith KA, Liou ML. c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function. International Immunology. 11: 361-71. PMID 10221648 DOI: 10.1093/Intimm/11.3.361  0.329
1999 Liou ML, Liou HC. The ubiquitin-homology protein, DAP-1, associates with tumor necrosis factor receptor (p60) death domain and induces apoptosis. The Journal of Biological Chemistry. 274: 10145-53. PMID 10187798 DOI: 10.1074/jbc.274.15.10145  0.412
1998 Tumang JR, Owyang A, Andjelic S, Jin Z, Hardy RR, Liou ML, Liou HC. c-Rel is essential for B lymphocyte survival and cell cycle progression. European Journal of Immunology. 28: 4299-312. PMID 9862367 DOI: 10.1002/(Sici)1521-4141(199812)28:12<4299::Aid-Immu4299>3.0.Co;2-Y  0.501
Show low-probability matches.